The Ridgewood Blog Brings a Free Market Laissez-faire Point of View to Local, New Jersey State and National Issues.
the staff of the Ridgewood blog
Ridgewood NJ, the number of measles cases reported this year in the U.S. is already equal to the total for all of 2023, prompting federal health officials to alert doctors and public health officials to possible outbreaks in their communities. So far only 58 cases have been reported across 17 states, including one in Camden County in New Jersey.
Continue reading Measles Outbreak: Does the Vaccine Received 20 to 50 Years Ago Still Work?
the staff of the Ridgewood blog
Trenton NJ, as part of the transition to routine, commercial access to COVID-19 vaccines, the New Jersey COVID-19 Vaccine Call Center is closing operations on March 28, the New Jersey Department of Health (NJDOH) announced today.
Continue reading New Jersey COVID-19 Vaccine Call Center Finally Ends Operations
the staff of the Ridgewood blog
Trenton NJ, Senator Anthony M. Bucco released the following statement in reaction to the New York Supreme Court ruling reinstating more than 1,400 New York City employees fired for being unvaccinated, including police, firefighters, and other New York City workers:
Continue reading Time for Governor Murphy to Reinstate Workers Fired for Refusing COVID Vaccine
the staff of the Ridgewood blog
Ridgewood NJ, in an interview with “60 Minutes” at the North American International Auto Show in Detroit, Michigan, US President Joe Biden said he believes that the COVID-19 “pandemic is over” while simultaneously acknowledging that the disease continues to be a “problem.” Notably, a White House team that reviewed the transcript of the interview, which aired September 18 but was taped last week, did not alert its COVID-19 response team about the declaration, leaving senior federal health officials surprised and without a coordinated response for the immediate reactions. President Biden had not originally planned to make headlines on COVID-19, nor had he discussed an end to the pandemic with his health advisors. The day after the interview aired, US HHS Secretary Xavier Becerra supported the president’s comments, saying that effective vaccines, tests, and treatments put the nation on a better path than earlier in the pandemic and noted the administration is reviewing whether it will renew the national declaration of a public health emergency.
Continue reading President Joe Biden Says the “PANDEMIC IS OVER”
the staff of the Ridgewood blog
Continue reading The Valley Hospital to offer 3rd Dose to Immunocompromised Patients
Clinical Contributors to this Story Thomas Bader, M.D. contributes to topics such as Medical Quality.
Hackensack NJ, With countries across the world beginning their COVID-19 vaccination plans, there’s a lot of information to consider before signing up to get your first shot.
As always while making a medical decision, you should talk to your doctor about the vaccine. Your doctor should have the latest information about the vaccine, availability and when you can it.
Continue reading Hackensack Meridian Health : Common Myths about COVID-19 Vaccines Explained
the staff of the Ridgewood compiled from the CDC website
Ridgewood NJ, In the United States, there is not yet an authorized or approved vaccine to prevent coronavirus disease 2019 (COVID-19). The federal government, through Operation Warp Speedexternal , has been working since the pandemic started to make one or more COVID-19 vaccines available as soon as possible. Although CDC does not have a role in developing COVID-19 vaccines, CDC has been working closely with health departments and partners to develop vaccination plans for when a vaccine is available.
With the possibility of one or more COVID-19 vaccines becoming available before the end of the year, here are things you need to know about where those plans currently stand.
the staff of the Ridgewood blog
Ridgewood NJ, Johns Hopkins Center for Health Security is reporting that according to multiple reports, the US CDC plans to issue COVID-19 vaccination cards so that individuals can verify their vaccination status, much like cards used for other vaccinations, such as the ICVP “yellow card” for yellow fever. Additionally, the CDC is reportedly designing templates for buttons and stickers that health departments and providers can provide to vaccinated individuals, similar to the “I Voted” stickers handed out to many voters on election day. These templates will be included in the CDC’s SARS-CoV-2 vaccination toolkit to “educate and promote vaccination.”
the staff of the Ridgewood blog
London UK, the U.K. has become the first country in the world to approve the coronavirus vaccine from Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), which has been shown to offer up to 95% protection against COVID-19. The first 800,000 doses will be available in the U.K. from next week (another 40M doses are on order). Two doses three weeks apart are required for protection and will first be offered to frontline health care workers and nursing home residents, followed by older adults. Other countries aren’t far behind: The U.S. and the EU also are vetting the Pfizer shot along with a similar vaccine made by competitor Moderna (NASDAQ:MRNA), and a similar nod by the FDA is expected as early as next week
Continue reading AstraZeneca Faces Hurdles to Regulatory Approval of COVID19 Vaccine
Continue reading FDA to Convene on Pfizer and BioNTech COVID Vaccine December 10th
the staff of the Ridgewood blog
University of Oxford , The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The data, published today in The Lancet, suggest that one of the groups most vulnerable to serious illness, and death from COVID-19, could build immunity.
British pharmaceutical giant AstraZeneca, which is working in collaboration with the University of Oxford, has previously said interim data showed their experimental vaccine had produced an immune response in older and younger adults.
Older adults have been shown to be at higher risk from COVID-19 and should be considered to be a priority for immunisation should any effective vaccine be developed for the disease. Reporting on data from a Phase II trial of the ChAdOx1 nCov-2019 vaccine, the authors write that volunteers in the trial demonstrate similar neutralising antibody titres, and T cell responses across all three age groups (18-55, 56-79, and 70+).
the staff of the Ridgewood blog
Red Bank NJ, Governor Phil Murphy and New Jersey Health Commissioner Judith Persichilli today announced the state’s COVID-19 vaccination plan, designed to provide equitable access to approved vaccine(s), achieve maximum community protection and build public trust in advance of an approved vaccine(s)
Continue reading Johnson & Johnson (J&J) published preliminary findings for COVID19 Vaccine
